Sanjay Mistry, PhD

San Diego, California,
Based at the La Jolla R&D Campus, Sanjay is the Vice President, NewCo Development Johnson & Johnson Innovation (JJI)-JJDC (JJI-JJDC). developing new growth platforms for pharmaceutical, medical device, consumer and digital health sectors through the creation of innovative startup companies that will be incubated and then developed externally with the purpose of de-risking the technology/science/business model, leveraging external financing & capabilities, and accelerating the innovation to acquire or license back into the J&J sectors.

Prior to joining JJI-JJDC, Sanjay was Head of Johnson & Johnson Innovation – JLABS @ San Diego where he was responsible for the P&L, sourcing and onboarding of strategically relevant companies, portfolio prioritization, nurturing the regional ecosystem and fostering opportunities for partnership with JNJ. During his time with JLABS @ San Diego, critical deals were completed with companies such as 1859, Lynx Bio & Cidara Therapeutics.

Before that, Sanjay led R&D finance operations for the Janssen Pharmaceuticals R&D CFO. Prior to this role, he led early-stage R&D divestments in partnership with Janssen Business Development (JBD) and Johnson & Johnson Innovation – JJDC, Inc., leading to a number of successful asset out-licenses and the formation of four new companies.

Sanjay received his PhD in Pharmacology and MSc In Clinical Pharmacology from The University of Aberdeen, UK and attained his BSc in Applied Biology/Biomedical Sciences at Nottingham Trent University, UK. He completed post-doctoral fellowships at the University of Pittsburgh Medical School and at the Scripps Research Institute, where he worked in the lab of the late Nobel Laureate Gerald Edelman. He is also a Life Science Kauffman Fellow of Class 14, the holder of 40 US and 160 foreign issued patents and has 20 peer-reviewed publications.
Speaking In
11:00 AM - 12:00 PM (PDT)
Wednesday, June 15
Do you have what it takes to entice the industry’s top investors? Bring your A-game as you…